Department of Anesthesiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Anesthesiology, Chiba University Hospital, Chiba, Japan.
Anesthesiology. 2022 Jul 1;137(1):15-27. doi: 10.1097/ALN.0000000000004254.
The low acceptance rate of continuous positive airway pressure therapy in postoperative patients with untreated obstructive sleep apnea (OSA) indicates the necessity for development of an alternative postoperative airway management strategy. The authors considered whether the combination of high-flow nasal cannula and upper-body elevation could improve postoperative OSA.
This nonblinded randomized crossover study performed at a single university hospital investigated the effect on a modified apnea hypopnea index, based exclusively on the airflow signal without arterial oxygen saturation criteria (flow-based apnea hypopnea index, primary outcome), of high-flow nasal cannula (20 l · min-1 with 40% oxygen concentration) with and without upper-body elevation in patients with moderate to severe OSA. Preoperative sleep studies were performed at home (control, no head-of-bed elevation) and in hospital (30-degree head-of-bed elevation). On the first and second postoperative nights, high-flow nasal cannula was applied with or without 30-degree head-of-bed elevation, assigned in random order to 23 eligible participants.
Twenty-two of the 23 (96%) accepted high-flow nasal cannula. Four participants resigned from the study. Control flow-based apnea hypopnea index (mean ± SD, 60 ± 12 events · h-1; n = 19) was reduced by 15 (95% CI, 6 to 30) events · h-1 with head-of-bed elevation alone (P = 0.002), 10.9 (95% CI, 1 to 21) events · h-1 with high-flow nasal cannula alone (P = 0.028), and 23 (95% CI, 13 to 32) events · h-1 with combined head-of-bed elevation and high-flow nasal cannula (P < 0.001). Compared to sole high-flow nasal cannula, additional intervention with head-of-bed elevation significantly decreased flow-based apnea hypopnea index by 12 events · h-1 (95% CI, 2 to 21; P = 0.022). High-flow nasal cannula, alone or in combination with head-of-bed elevation, also improved overnight oxygenation. No harmful events were observed.
The combination of high-flow nasal cannula and upper-body elevation reduced OSA severity and nocturnal hypoxemia, suggesting a role for it as an alternate postoperative airway management strategy.
未经治疗的阻塞性睡眠呼吸暂停(OSA)术后患者对持续气道正压通气治疗的接受率低,这表明需要开发替代的术后气道管理策略。作者考虑了高流量鼻导管联合上身抬高是否可以改善术后 OSA。
这是一项在一家大学医院进行的非盲随机交叉研究,根据仅基于气流信号而不考虑动脉血氧饱和度标准的改良呼吸暂停低通气指数(主要结局),研究了高流量鼻导管(20 l·min-1,氧浓度 40%)联合和不联合上身抬高对中重度 OSA 患者的影响。术前睡眠研究在家庭(对照组,无床头抬高)和医院(床头抬高 30°)进行。在术后第一和第二晚,随机分配 23 名符合条件的参与者接受高流量鼻导管治疗,分别为高流量鼻导管加或不加 30°床头抬高。
23 名参与者中有 22 名(96%)接受了高流量鼻导管。4 名参与者退出了研究。单独使用床头抬高可使对照组的基于流量的呼吸暂停低通气指数(平均±标准差,60±12 次·h-1;n=19)降低 15 次·h-1(95%CI,6 至 30)(P=0.002),单独使用高流量鼻导管可降低 10.9 次·h-1(95%CI,1 至 21)(P=0.028),联合使用床头抬高和高流量鼻导管可降低 23 次·h-1(95%CI,13 至 32)(P<0.001)。与单独使用高流量鼻导管相比,联合床头抬高可显著降低基于流量的呼吸暂停低通气指数 12 次·h-1(95%CI,2 至 21;P=0.022)。单独使用高流量鼻导管或联合使用床头抬高也改善了夜间氧合。未观察到有害事件。
高流量鼻导管联合上身抬高降低了 OSA 严重程度和夜间低氧血症,表明其作为一种替代术后气道管理策略的作用。